HK1028561A1 - Pharmaceutical composition for reducing production of mcp-1 protein - Google Patents
Pharmaceutical composition for reducing production of mcp-1 proteinInfo
- Publication number
- HK1028561A1 HK1028561A1 HK00107851A HK00107851A HK1028561A1 HK 1028561 A1 HK1028561 A1 HK 1028561A1 HK 00107851 A HK00107851 A HK 00107851A HK 00107851 A HK00107851 A HK 00107851A HK 1028561 A1 HK1028561 A1 HK 1028561A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- mcp
- protein
- pharmaceutical composition
- reducing production
- reducing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Surgery (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT97MI001789A IT1293795B1 (it) | 1997-07-28 | 1997-07-28 | Farmaco attivo nel ridurre la produzione di proteina mcp-1 |
PCT/EP1998/004924 WO1999004770A2 (en) | 1997-07-28 | 1998-07-22 | A pharmaceutical composition active in reducing production of mcp-1 protein |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1028561A1 true HK1028561A1 (en) | 2001-02-23 |
Family
ID=11377642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK00107851A HK1028561A1 (en) | 1997-07-28 | 2000-12-07 | Pharmaceutical composition for reducing production of mcp-1 protein |
Country Status (16)
Country | Link |
---|---|
US (1) | US6534534B1 (ja) |
EP (1) | EP1005332B1 (ja) |
JP (2) | JP4651191B2 (ja) |
AR (1) | AR016382A1 (ja) |
AT (1) | ATE251902T1 (ja) |
AU (1) | AU744492B2 (ja) |
CA (1) | CA2300289C (ja) |
DE (1) | DE69819012T2 (ja) |
DK (1) | DK1005332T3 (ja) |
ES (1) | ES2207858T3 (ja) |
HK (1) | HK1028561A1 (ja) |
IT (1) | IT1293795B1 (ja) |
PT (1) | PT1005332E (ja) |
SI (1) | SI1005332T1 (ja) |
WO (1) | WO1999004770A2 (ja) |
ZA (1) | ZA986636B (ja) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1293795B1 (it) * | 1997-07-28 | 1999-03-10 | Angelini Ricerche Spa | Farmaco attivo nel ridurre la produzione di proteina mcp-1 |
ITMI20062254A1 (it) * | 2006-11-24 | 2008-05-25 | Acraf | Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca |
AU2009221063B2 (en) * | 2008-03-07 | 2013-03-21 | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. | 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, and CX3CR1 |
LT2254869T (lt) * | 2008-03-07 | 2017-08-10 | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. | Nauji 1-benzil-3-hidroksimetilindazolo dariniai ir jų panaudojimas gydyme ligų, susijusių su cx3cr1 ir p40 raiška |
US8461194B2 (en) | 2008-03-07 | 2013-06-11 | Aziende Chimiche Riunite Angelini Francesco A. C. R. A. F. S. P. A. | 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and P40 |
MX2012001520A (es) | 2009-08-03 | 2012-06-01 | Acraf | Proceso para la preparacion de 1-bencil-3-hidroximetil-1h-indazol y sus derivados e intermediarios de magnesio requeridos. |
UA108742C2 (uk) * | 2009-09-23 | 2015-06-10 | Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1 | |
CA2789952C (en) | 2010-02-25 | 2018-06-12 | Prairie Ventures, L.L.C. | System and method for anatomical pathology sample handling, storage, and analysis |
US8999292B2 (en) | 2012-05-01 | 2015-04-07 | Translatum Medicus Inc. | Methods for treating and diagnosing blinding eye diseases |
JP6944442B2 (ja) | 2015-06-12 | 2021-10-06 | ベットーレ リミテッド ライアビリティー カンパニーVettore, Llc | 疾患を治療するためのmct4阻害剤 |
BR112019011825A2 (pt) | 2016-12-12 | 2019-10-22 | Vettore Llc | composto, enantiômero isolado, composição farmacêutica, método para inibir a atividade do transportador de monocarboxilato mct4, ou um mutante do mesmo, em uma amostra biológica, método para inibir a atividade do transportador de monocarboxilato mct4, ou um mutante do mesmo, em relação ao transportador de monocarboxilato mct1, ou um mutante do mesmo, em um paciente, método para tratar um distúrbio mediado por transportador de monocarboxilato mct4 em um sujeito que necessite do mesmo, uso de um composto e método para obter um efeito em um paciente |
WO2020261158A1 (en) | 2019-06-25 | 2020-12-30 | Translatum Medicus Inc. | Processes of making 2-((1-benzyl-1h-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1230441B (it) * | 1989-02-07 | 1991-10-23 | Acraf | Eteri della serie dell'indazolo |
US5100899A (en) * | 1989-06-06 | 1992-03-31 | Roy Calne | Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof |
IT1253703B (it) * | 1991-04-22 | 1995-08-23 | Angelini Francesco Ist Ricerca | Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie |
AU5537994A (en) * | 1992-10-22 | 1994-05-09 | Mallinckrodt Medical, Inc. | Therapeutic treatment for inhibiting vascular restenosis |
US5563145A (en) * | 1994-12-07 | 1996-10-08 | American Home Products Corporation | Rapamycin 42-oximes and hydroxylamines |
JPH08333262A (ja) * | 1995-04-07 | 1996-12-17 | Chugai Pharmaceut Co Ltd | 免疫抑制剤 |
US6113898A (en) * | 1995-06-07 | 2000-09-05 | Idec Pharmaceuticals Corporation | Human B7.1-specific primatized antibodies and transfectomas expressing said antibodies |
DE19538402A1 (de) * | 1995-10-14 | 1997-04-17 | Boehringer Mannheim Gmbh | Lipidalkohole als neue immunsuppressive und antivirale Arzneimittel |
JPH09165339A (ja) * | 1995-10-27 | 1997-06-24 | American Home Prod Corp | ラパマイシンを付与したドナー脾細胞を用いる臓器移植の延長 |
IT1276031B1 (it) * | 1995-10-31 | 1997-10-24 | Angelini Ricerche Spa | Composizione farmaceutica per il trattamento delle malattie autoimmuni |
US5780462A (en) * | 1995-12-27 | 1998-07-14 | American Home Products Corporation | Water soluble rapamycin esters |
IT1293795B1 (it) * | 1997-07-28 | 1999-03-10 | Angelini Ricerche Spa | Farmaco attivo nel ridurre la produzione di proteina mcp-1 |
-
1997
- 1997-07-28 IT IT97MI001789A patent/IT1293795B1/it active IP Right Grant
-
1998
- 1998-07-22 WO PCT/EP1998/004924 patent/WO1999004770A2/en active IP Right Grant
- 1998-07-22 CA CA002300289A patent/CA2300289C/en not_active Expired - Fee Related
- 1998-07-22 JP JP2000503829A patent/JP4651191B2/ja not_active Expired - Fee Related
- 1998-07-22 ES ES98943862T patent/ES2207858T3/es not_active Expired - Lifetime
- 1998-07-22 AU AU91601/98A patent/AU744492B2/en not_active Ceased
- 1998-07-22 DE DE69819012T patent/DE69819012T2/de not_active Expired - Lifetime
- 1998-07-22 EP EP98943862A patent/EP1005332B1/en not_active Expired - Lifetime
- 1998-07-22 AT AT98943862T patent/ATE251902T1/de active
- 1998-07-22 US US09/463,666 patent/US6534534B1/en not_active Expired - Lifetime
- 1998-07-22 DK DK98943862T patent/DK1005332T3/da active
- 1998-07-22 SI SI9830573T patent/SI1005332T1/xx unknown
- 1998-07-22 PT PT98943862T patent/PT1005332E/pt unknown
- 1998-07-24 ZA ZA986636A patent/ZA986636B/xx unknown
- 1998-07-28 AR ARP980103695A patent/AR016382A1/es unknown
-
2000
- 2000-12-07 HK HK00107851A patent/HK1028561A1/xx not_active IP Right Cessation
-
2009
- 2009-11-09 JP JP2009270715A patent/JP5086322B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2010047609A (ja) | 2010-03-04 |
AU9160198A (en) | 1999-02-16 |
US6534534B1 (en) | 2003-03-18 |
DE69819012T2 (de) | 2004-08-12 |
JP2001510793A (ja) | 2001-08-07 |
JP4651191B2 (ja) | 2011-03-16 |
ES2207858T3 (es) | 2004-06-01 |
DK1005332T3 (da) | 2004-02-09 |
JP5086322B2 (ja) | 2012-11-28 |
WO1999004770A2 (en) | 1999-02-04 |
PT1005332E (pt) | 2004-03-31 |
CA2300289C (en) | 2007-11-20 |
ZA986636B (en) | 1999-02-04 |
WO1999004770A3 (en) | 1999-04-15 |
ATE251902T1 (de) | 2003-11-15 |
AU744492B2 (en) | 2002-02-28 |
CA2300289A1 (en) | 1999-02-04 |
ITMI971789A1 (it) | 1999-01-28 |
EP1005332B1 (en) | 2003-10-15 |
SI1005332T1 (en) | 2004-02-29 |
EP1005332A2 (en) | 2000-06-07 |
AR016382A1 (es) | 2001-07-04 |
IT1293795B1 (it) | 1999-03-10 |
DE69819012D1 (de) | 2003-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA987552B (en) | Pharmaceutical composition for combination of piperidino-alkanol-decongestant | |
ZA987800B (en) | Pharmaceutical composition of meloxicam | |
HUP9701554D0 (en) | Pharmaceutical composition containing plazma proteins | |
ZA9810490B (en) | 2-Aryl-8-oxodihydropurine derivative process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor | |
HUP9601698A3 (en) | Pharmaceutical composition of adiabetical activity | |
HUP0101580A3 (en) | Pharmaceutical compositions capable of being gelled | |
IL123986A0 (en) | Antithombotic agents process for their preparation and pharmaceutical compositions comprising them | |
GB9706089D0 (en) | Pharmaceutical composition | |
HU9502918D0 (en) | Pharmaceutical composition of antihypertriglyceridemic activity | |
GB2343117B (en) | Benzimidazole pharmaceutical composition and process of preparation | |
HK1028561A1 (en) | Pharmaceutical composition for reducing production of mcp-1 protein | |
EG22344A (en) | Process for preparing of novel pharmaceutical composition | |
IL134521A (en) | Pharmaceutical composition for enhancing the bioavailability of fexofenadine and its derivatives | |
HUP0202519A2 (en) | Production of proteins | |
IL114673A0 (en) | Pharmaceutical compositions containing protein | |
HUP9802716A3 (en) | Pharmaceutical composition of analgesic activity | |
ID24527A (id) | Proses pembuatan senyawa-senyawa farmasi | |
GB2321190B (en) | Pharmaceutical composition | |
IL134050A0 (en) | A pharmaceutical composition active in reducing production of mcp-1 protein | |
ZA981441B (en) | Process for preparation of heterocyclic thiol | |
GB9720963D0 (en) | Pharmaceutical compositions and method of production | |
HU9802107D0 (en) | Pharmaceutical composition containing plazma proteins | |
IL114388A0 (en) | Manufacture of pharmaceutical compositions comprising certain arylalkyl-amides | |
GB9703754D0 (en) | Process for preparation of heterocyclic thiol | |
GB9703753D0 (en) | Process for preparation of heterocyclic thiol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20170722 |